| Literature DB >> 32435395 |
Rita Meleddu1, Simona Distinto1, Filippo Cottiglia1, Rossella Angius2, Pierluigi Caboni1, Andrea Angeli3, Claudia Melis1, Serenella Deplano1, Stefano Alcaro4, Francesco Ortuso4, Claudiu T Supuran3, Elias Maccioni1.
Abstract
In the present study we investigated the structure-activity relationships of a new series of 4-[(3-ethyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides (EMAC10101a-m). All synthesized compounds, with the exception of compound EMAC10101k, preferentially inhibit off-target hCA II isoform. Within the series, compound EMAC10101d, bearing a 2,4-dichorophenyl substituent in position 4 of the dihydrothiazole ring, was the most potent and selective toward hCA II with an inhibitory activity in the low nanomolar range.Entities:
Year: 2020 PMID: 32435395 PMCID: PMC7236253 DOI: 10.1021/acsmedchemlett.9b00644
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345